ICU
SeaStar Medical Holding Corp
+0.04 (+1.30%)3.12USD6.9K成交股數13.7M市值–本益比(近四季)8.0股價營收比+82.0%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 615K+110% | 495K+639% | 183K+169% | 338K | 293K | 67K | 68K | 0.00 | 0.00 | 0.00 | – | – |
| 營業成本 | 54K | 46K | 14K | 27K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – |
| 毛利 | 561K+91% | 449K+570% | 169K+149% | 311K | 293K | 67K | 68K | 0.00 | 0.00 | 0.00 | – | – |
| 毛利率 | 91.2% | 90.7% | 92.3% | 92.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – |
| 研發費用 | 2.5M | 2.3M | 1.9M | 1.0M | 2.4M | 2.7M | 2.3M | 2.3M | 1.7M | 1.1M | 2.0M | 1.7M |
| 銷售管理費用 | 1.8M | 1.7M | 1.9M | 1.0M | 1.7M | 2.1M | 2.2M | 2.3M | 2.3M | 1.9M | 1.8M | 2.9M |
| 營業利益 | −3.8M-1% | −3.6M-24% | −3.6M-20% | −1.8M-62% | −3.8M-3% | −4.8M+62% | −4.5M+19% | −4.7M+2% | −4.0M | −2.9M | −3.8M | −4.6M |
| 營業利益率 | -616.4% | -727.9% | -1,955.7% | -519.5% | -1,304.4% | -7,114.9% | -6,552.9% | – | – | – | – | – |
| 稅後淨利 | −3.7M-1% | −3.5M-20% | −3.5M-22% | −2.0M-38% | −3.8M-70% | −4.4M-39% | −4.5M+83% | −3.2M-54% | −12.7M | −7.2M | −2.4M | −7.1M |
| 淨利率 | -606.5% | -711.3% | -1,897.3% | -592.3% | -1,287.4% | -6,595.5% | -6,585.3% | – | – | – | – | – |
| 稀釋 EPS | – | – | – | -0.18-83% | -0.44-91% | 0.23-103% | -1.10-73% | -1.03+91% | -4.73 | -9.02 | -4.10 | -0.54 |
| 稀釋股數 | – | – | – | 11.3M | 8.6M | 3.7M | 4.1M | 3.2M | 2.7M | 802K | 597K | 13.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | – | – | – | 6.3M | 5.3M | 1.8M | 2.1M | 1.2M | 5.0M | 73K | 13K | 725K |
| 應收帳款 | 208K | 179K | 221K | 217K | 110K | 112K | 68K | – | – | – | – | – |
| 存貨 | 77K | 57K | 83K | 77K | 44K | 0.00 | 0.00 | – | – | – | – | – |
| 總資產 | 8.6M | 11.3M | 15.5M | 8.4M | 14.2M | 4.7M | 4.6M | 3.5M | 7.7M | 2.5M | 2.6M | 3.6M |
| 有息負債 | – | – | – | – | – | – | 0.00 | 0.00 | 1.1M | 5.7M | – | 5.7M |
| 總負債 | 4.4M | 3.9M | 4.1M | 5.0M | 7.0M | 6.8M | 6.6M | 10.4M | 12.2M | 18.5M | 14.4M | 27.0M |
| 股東權益 | 4.3M | 7.3M | 11.5M | 3.3M | 565K | −2.2M | −2K | −6.9M | −4.5M | −16.0M | −11.8M | −23.4M |
| 負債比 | 50.3% | 35.1% | 26.2% | 60.1% | 49.5% | 146.9% | 144.7% | 299.0% | 157.8% | 738.6% | 553.0% | 740.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | 2.1M | 1.2M | 3.9M | −5.6M | – | −5.0M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.8M | – | – | −2.7M-24% | – | – | – | −3.5M | – | – | −2.3M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 1.2M
| Pediatric Scds | 1.2M | 100.0% | +1100.0% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.2M | +814.1% | −12.2M | -984.6% | – | – |
| FY2024 | 135K | – | −24.8M | -18,392.6% | -6.63 | – |
| FY2023 | 0.00 | – | −26.2M | –% | -30.26 | – |
| FY2022 | – | – | −12.2M | –% | -1.48 | – |
| FY2021 | 12K | – | −4.6M | -38,883.2% | -0.63 | – |